Company · CIK 1340744
Altus Pharmaceuticals Inc.
| CIK | 1340744 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2006-03-30 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-160174 | 2009-06-23 | 2009-07-02 | 2 | |
| 333-141414 | 2007-03-19 | 2007-04-19 | 4 | |
| 333-129037 | 2005-10-17 | 2006-01-26 | 8 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2009-07-02 | EFFECTDeclared effective | 333-160174 | 9999999995-09-001860 |
| 2009-06-23 | S-3Shelf registered | 333-160174 | 0000950123-09-016357 |
| 2007-04-19 | 424B5Shelf takedown | 333-141414 | 0000950135-07-002304 |
| 2007-04-10 | 424B5Shelf takedown | 333-141414 | 0000950135-07-002158 |
| 2007-04-05 | EFFECTDeclared effective | 333-141414 | 9999999995-07-001246 |
| 2007-03-19 | S-3Shelf registered | 333-141414 | 0000950135-07-001735 |
| 2006-01-26 | 424B4Final prospectus | 333-129037 | 0000950135-06-000323 |
| 2006-01-25 | S-1/AAmendment | 333-129037 | 0000950135-06-000307 |
| 2006-01-23 | S-1/AAmendment | 333-129037 | 0000950135-06-000247 |
| 2006-01-11 | S-1/AAmendment | 333-129037 | 0000950135-06-000105 |
| 2005-12-27 | S-1/AAmendment | 333-129037 | 0000950135-05-007137 |
| 2005-11-30 | S-1/AAmendment | 333-129037 | 0000950135-05-006733 |
| 2005-11-02 | S-1/AAmendment | 333-129037 | 0000950135-05-006166 |
| 2005-10-17 | S-1Registration filed | 333-129037 | 0000950135-05-005771 |